In the present study, we have used four different cancer cell types (breast and cervical cancer, osteosarcoma and glioblastoma cells) to analyze the effects of DNMT2/TRDMT1 gene knockout during doxorubicin- and etoposide-induced senescence and the impact of AZA post-treatment. Here, TRDMT1 is linked to glioblastoma.